| Patient | Thomas Jefferson |
|---|---|
| Date of birth | 1979-04-13 |
| Identifiers | MRN HR-EN005-SYN; SSN (made up) 000-05-2276 |
| Document date | 2026-05-21 |
| Author | Nathaniel Beaumont-Ruiz, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week review of the headache diary, seen the same day by headache medicine. [S]
Mr. Jefferson returns with his 14-day headache diary and is seen by Dr. Haddad of headache medicine on the same day. The bout that began three weeks ago has eased. His diary shows headache on 7 of 14 days: each attack began between nine and ten in the morning, built over an hour to a moderate or severe throbbing pain across the forehead and temples, worse with reading and climbing stairs, with sensitivity to light and noise on every headache day and nausea on four, and lasted six to ten hours, settling by evening. He had no visual or other aura. The last seven days have been headache-free. He took naproxen on four days, with metoclopramide on two, and the pain was reduced but rarely gone after two hours; he has taken no combination analgesic since intake. Counting the week before intake, he has had 13 migraine days in the past four weeks. He has been sleeping six hours, has kept to two cups of coffee and has not skipped lunch. He has had no weakness, numbness, fever or change in vision. [S]
| Element | Detail |
|---|---|
| Diary | Headache on 7 of 14 days; morning onset, six to ten hours, throbbing, light and noise sensitivity, nausea on four days; no aura |
| Past four weeks | 13 migraine days |
| Acute medicine | Naproxen on four days, metoclopramide on two; partial relief |
| Combination analgesic | None since intake |
| Red flags | None |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or weight loss |
| Eyes | Negative | No visual aura or loss of vision |
| Neurological | Positive | Migraine attacks as in the diary; no weakness, numbness or speech change |
| Psychiatric | Negative | Frustrated by lost work; mood otherwise steady |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a week | One tablet at headache onset, may repeat once after 12 hours; no more than two days a week | Oral route | 2026-05-07 | active | S |
| Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a week | One tablet with the acute medicine when nausea is present, no more than once a day | Oral route | 2026-05-07 | active | S |
| Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a month | One tablet at attack onset with naproxen, may repeat once after 2 hours; up to 200 mg a day | Oral route | 2026-05-21 | active | S |
| Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine prevention | One capsule each evening | Oral route | 2026-05-21 to 2026-06-18 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-21 | Body height | 189 | cm | S |
| 2026-05-21 | Body weight | 76.2 | kg | S |
| 2026-05-21 | Body mass index (BMI) [Ratio] | 21.3 | kg/m2 | S |
| 2026-05-21 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-05-21 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-05-21 | Heart rate | 70 | /min | S |
| 2026-05-21 | Respiratory rate | 14 | /min | S |
| 2026-05-21 | Body temperature | 36.6 | Cel | S |
| 2026-05-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Vital signs recorded on 2026-05-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Comfortable today; blood pressure 122/78, pulse 70 |
| Eyes | Fundi with sharp discs; visual fields full |
| Neurological | Cranial nerves, strength, sensation, reflexes, coordination and gait normal |
| Head and neck | Mild tenderness of the neck and shoulder muscles; temporal arteries normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent disabling headaches since early adulthood, in bouts lasting days to weeks, now in the seventh day of a bout; under evaluation, with a two-week headache diary and a headache medicine consultation; no red flags | resolved | confirmed | R51.9 | S — Synthetic presenting problem anchored to his documented periodical headaches; superseded when the consultation confirmed migraine without aura. |
| Migraine without aura, episodic, with bouts of near-daily attacks lasting two to three weeks; ICHD-3 criteria met in a two-week diary; synthetic modern diagnosis linked to his documented periodical headaches, which historians have usually but not unanimously called migraine | active | confirmed | G43.009 | S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0013), so this is not a claim about his real diagnosis. |
| Stiffness and weakness of the right wrist and hand after a dislocation that healed out of place in early middle age; writing is slow and painful after about an hour | active | confirmed | M25.631 | S — Synthetic modern coding of the documented badly healed right wrist dislocation. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Red-flag screen (SNNOOP10): systemic signs, neurological signs, sudden or new pattern, onset after 50, positional or Valsalva features, papilledema, progressive course | Every visit | Completed today | No red flags; normal neurological examination and fundi |
| Survey | Headache diary: headache and migraine days, attack features, triggers | Every visit | Completed today | 14 days kept: headache on the first 7 days, all meeting migraine features; 13 migraine days in the past four weeks |
| Medication safety | Acute-medicine days (medication overuse headache limits: triptan fewer than 10, NSAID fewer than 15 days a month) | Every visit | Completed today | Naproxen on four days in 14; no combination analgesic since intake |
| Medication safety | Acute treatment response (pain-free at two hours, return to work) | Every visit | Completed today | Naproxen gave partial relief, rarely pain-free at two hours; triptan added |
| Medication safety | Cardiovascular screen before a triptan | Before the first triptan prescription | Completed today | No chest pain, vascular disease, uncontrolled blood pressure or smoking; blood pressure 122/78 |
| Medication safety | Propranolol tolerability: pulse, blood pressure, tiredness, exercise tolerance, wheeze, cold hands, sleep | Four weeks after starting or changing the dose, then each visit | Completed today | Before starting: pulse 70, blood pressure 122/78; no asthma, heart block or depression |
| Examination | Preventive efficacy (at least 50% fewer migraine days) | At two to three months on an adequate dose | Due | Propranolol started today; efficacy judged at the three-month review |
| Survey | Disability (MIDAS, recorded as its five items, and HIT-6) | At baseline and after about three months of prevention | Up to date | MIDAS 39 (grade IV) and HIT-6 66 at intake; repeat at three months |
| Survey | Mood (PHQ-9) and anxiety (GAD-7), including on a beta-blocker | At baseline, four to six weeks after starting a preventive that can affect mood, then at each review | Up to date | PHQ-9 6 and GAD-7 7 at intake; repeat four to six weeks after starting propranolol |
| Imaging | Neuroimaging | Only for red flags or a change in pattern | Not indicated | Stable pattern for more than twenty years, normal examination, no red flags |
| Self-management | Sleep, meals, caffeine and work-stress plan | Every visit | Completed today | Six hours of sleep, two cups of coffee, regular lunch |
| Referral | Headache medicine consultation | At diagnosis | Completed today | Seen by Dr. Haddad today |
| Referral | Occupational therapy visit for the right wrist and writing | Within four weeks of intake | Ordered | Requested at intake; awaiting an appointment |
Goal progress:
Guideline basis: Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update (2024); The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice (2019); Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians (2025); Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question (2013)
Follow-up: Six-week review in four weeks. Diary continued. Call for a headache unlike his usual attacks, weakness, numbness, fever or a stiff neck. Next scheduled visit 2026-06-18: six-week review, four weeks after starting propranolol: tolerability, attacks, acute medicine days and the wrist. [S]